Get Started

IPH

Innate Pharma (IPH)

Innate Pharma

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:IPH

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Date	Time	Source	Headline	Symbol	Company
07/11/2024	12:21PM	iHub Newswire	FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
11/08/2018	1:00AM	GlobeNewswire	INNATE PHARMA : Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er novembre 2018	EU:IPH	Innate Pharma
11/02/2018	2:01AM	GlobeNewswire Inc.	INNATE PHARMA : clinical data featured as oral presentations at two major upcoming oncology conferences	EU:IPH	Innate Pharma
11/02/2018	2:00AM	GlobeNewswire	INNATE PHARMA annonce la présentation de données cliniques à deux prochains congrès majeurs d'oncologie	EU:IPH	Innate Pharma
11/02/2018	2:00AM	GlobeNewswire	INNATE PHARMA : clinical data featured as oral presentations at two major upcoming oncology conferences	EU:IPH	Innate Pharma
10/23/2018	10:31AM	Dow Jones News	AstraZeneca Adds Cancer Drugs to Pipeline with Innate Pharma Deal	EU:IPH	Innate Pharma
10/23/2018	3:20AM	Dow Jones News	AstraZeneca Buys EUR62.6 Million Stake in Innate Pharma	EU:IPH	Innate Pharma
10/23/2018	1:01AM	GlobeNewswire Inc.	Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca	EU:IPH	Innate Pharma
10/23/2018	1:00AM	GlobeNewswire	Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca	EU:IPH	Innate Pharma
10/23/2018	1:00AM	GlobeNewswire	Innate Pharma renforce et étend sa collaboration de développement en oncologie avec AstraZeneca	EU:IPH	Innate Pharma
10/20/2018	9:01AM	GlobeNewswire Inc.	INNATE PHARMA : Phase II results from monalizumab/cetuximab in head and neck cancer at ESMO	EU:IPH	Innate Pharma
10/20/2018	9:00AM	GlobeNewswire	INNATE PHARMA : Résultats de phase II de monalizumab avec cetuximab dans les cancers de la tête et du cou à ESMO	EU:IPH	Innate Pharma
10/20/2018	9:00AM	GlobeNewswire	INNATE PHARMA : Phase II results from monalizumab/cetuximab in head and neck cancer at ESMO	EU:IPH	Innate Pharma
10/16/2018	1:01AM	GlobeNewswire Inc.	INNATE PHARMA : data presentations on monalizumab at the ESMO annual meeting 2018	EU:IPH	Innate Pharma
10/16/2018	1:00AM	GlobeNewswire	INNATE PHARMA : data presentations on monalizumab at the ESMO annual meeting 2018	EU:IPH	Innate Pharma
10/16/2018	1:00AM	GlobeNewswire	INNATE PHARMA : présentation de données pour monalizumab lors du congrès annuel ESMO	EU:IPH	Innate Pharma
09/29/2018	2:31AM	GlobeNewswire Inc.	Innate Pharma reports IPH4102 results in advanced Cutaneous T Cell Lymphoma (CTCL)	EU:IPH	Innate Pharma
09/29/2018	2:30AM	GlobeNewswire	Innate Pharma présente des résultats pour IPH4102 dans les Lymphomes T Cutanés (LTC) avancés	EU:IPH	Innate Pharma
09/29/2018	2:30AM	GlobeNewswire	Innate Pharma reports IPH4102 results in advanced Cutaneous T Cell Lymphoma (CTCL)	EU:IPH	Innate Pharma
09/14/2018	1:01AM	GlobeNewswire Inc.	Innate Pharma reports first half 2018 financial results and business update	EU:IPH	Innate Pharma
09/14/2018	1:00AM	GlobeNewswire	Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2018	EU:IPH	Innate Pharma
09/14/2018	1:00AM	GlobeNewswire	Innate Pharma reports first half 2018 financial results and business update	EU:IPH	Innate Pharma
09/12/2018	1:01AM	GlobeNewswire Inc.	INNATE PHARMA : first patient in the Phase I study of IPH5401 in combination with durvalumab	EU:IPH	Innate Pharma
09/12/2018	1:00AM	GlobeNewswire	INNATE PHARMA : first patient in the Phase I study of IPH5401 in combination with durvalumab	EU:IPH	Innate Pharma
09/12/2018	1:00AM	GlobeNewswire	INNATE PHARMA : premier patient dans l'étude de Phase I évaluant IPH5401 en combinaison avec durvalumab	EU:IPH	Innate Pharma
09/10/2018	1:01AM	GlobeNewswire Inc.	Innate Pharma announces data presentations at upcoming scientific meetings	EU:IPH	Innate Pharma
09/10/2018	1:00AM	GlobeNewswire	Innate Pharma annonce la présentation de données lors de prochains congrès scientifiques	EU:IPH	Innate Pharma
09/10/2018	1:00AM	GlobeNewswire	Innate Pharma announces data presentations at upcoming scientific meetings	EU:IPH	Innate Pharma
08/23/2018	1:00AM	GlobeNewswire	INNATE PHARMA ANNOUNCES A CHANGE TO ITS 2018 FINANCIAL CALENDAR	EU:IPH	Innate Pharma
08/23/2018	1:00AM	GlobeNewswire	INNATE PHARMA ANNONCE UNE MODIFICATION DE SON CALENDRIER FINANCIER 2018	EU:IPH	Innate Pharma